FDA issued a Warning Letter to Magellan Diagnostics, Inc. on 10/23/2017 as a result of this inspection.
FDA investigators audited the Magellan Diagnostics - North Billerica, MA, United States facility and issued 9 inspectional observations (via FDA 483) on 29 Jun 2017.
Add To Cart
- Category: Medical Devices & Rad Health
- Number of Observations: 9
- Inspection end: 29 Jun 2017
- Location: North Billerica, United States
- FEI: 1218996